Sun BioPharma, Inc. to Present at the 2017 Marcum MicroCap Conference in New York on June 15, 2017
MINNEAPOLIS, June 07, 2017 (GLOBE NEWSWIRE) -- Sun BioPharma, Inc., (OTCQB:SNBP), a clinical stage biopharmaceutical company developing disruptive therapeutics for the treatment of pancreatic diseases, today announced that David Kaysen, the Company’s Chief …